- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03518632
Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE) (APACHE)
Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer
Study Overview
Status
Intervention / Treatment
Detailed Description
The purpose of this study is to investigate the effects of a preoperative exercise program in patients with primary or secondary liver cancer undergoing hepatectomy. Preoperative exercise programs have been shown to be effective in other cancer populations, but have been poorly studied in patients with liver cancer. For these patients, it remains unclear what the optimal composition of such programs should be and how they should be delivered. Outcome measures in this study will include preoperative outcomes (oxygen consumption, quality of life, fatigue and physical activity level, anthropometric measures, plasma concentrations of hepatokines) and postoperative outcomes (length of hospital stay and postoperative complications).
After the study is explained and consent obtained, subjects will be tested on a submaximal exercise on cycloergometer with gas exchanges analysis and with pre and post blood test. Then, they will answer various questionnaires assessing physical activity, quality of life and fatigue.
Patients scheduled for liver resection will be randomized to one of two groups. The first group (experimental group) will be subdivided into two groups: interval training 1 and interval training 2, which differentiate themselves by two different intensities.The second group (control group) will receive standard care.
The prehabilitation program will last 6 weeks with 3 sessions per week and will consist in two interval training programs on a cycloergometer with two different intensities.
One month after surgery, peri and postoperative complications will be noted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Besançon, France, 25000
- Chirurgie digestive, viscérale et cancérologique
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women aged >18 years old.
- Patients with primary liver cancer, biliary tract cancer, liver metastasis endorsed in the University Hospital of Besancon
- No opposition of patients
- Join a French social security or receiving such a scheme
Exclusion Criteria:
- Legal incapacity or limited legal capacity
- Patients being in the disqualification of another study or under the national register of volunteers
- Patients unlikely to cooperate or anticipated low cooperation
- Patients with a maximal oxygen consumption above 35 ml/min/kg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
|
Patients in control group will follow the standard oncologic care.
They will perform only 2 sub-maximal exercises.
|
Experimental: Interval training 1
|
Patients in experimental group will perform a 6 weeks' physical activity program with 3 sessions per week.
Physical activity intervention will consist in 2 different interval training programs on cycloergometer: Interval training 1 and Interval training 2, with a difference in exercise intensities.
|
Experimental: Interval training 2
|
Patients in experimental group will perform a 6 weeks' physical activity program with 3 sessions per week.
Physical activity intervention will consist in 2 different interval training programs on cycloergometer: Interval training 1 and Interval training 2, with a difference in exercise intensities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Oxgen consumption at anaerobic threshold :
Time Frame: 6 weeks
|
Oxygen consumption at anaerobic threshold will be assessed at baseline and at the end of the 6 weeks' program with a submaximal exercise performed on cycloergometer
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative complications with the Dindo Clavien classification :
Time Frame: One month after surgery
|
Postoperative complications will be assessed using the Dindo Clavien classification which consists in a 7 grades classification (I, II, IIIa, IIIb, IVa, IVb and V).
|
One month after surgery
|
Intensive care stay :
Time Frame: One month after surgery
|
Postoperative intensive care stay will be evaluated (number of days).
|
One month after surgery
|
Changes of Hepatokines plasmatic concentrations :
Time Frame: Comparison between plasmatic concentrations pre-exercise (day 1), post exercise (day 1) and at 6 weeks
|
Fetuin A (ng/mL) concentrations will be analyzed.
|
Comparison between plasmatic concentrations pre-exercise (day 1), post exercise (day 1) and at 6 weeks
|
Hepatokines plasmatic concentrations :
Time Frame: Comparison between plasmatic concentrations pre-exercise (day 1), post exercise (day 1) and at 6 weeks
|
Fibroblast Growth Factor 21 (FGF21) (pg/mL) concentrations will be analyzed.
|
Comparison between plasmatic concentrations pre-exercise (day 1), post exercise (day 1) and at 6 weeks
|
Changes in Physical activity level :
Time Frame: Comparison between baseline, after the 6 weeks' program
|
Physical activity level will be measured using the long-form of the International Physical Activity Questionnaire (IPAQ).
It consist in a description of the physical activity level by assessing 5 activity domains during the 7 last days.
Physical activity level is expressed in Metabolic Equivalent Tasks (METs).
It enables to classify patients in 3 categories : low physical activity level, moderate physical activity level and high physical activity level.
|
Comparison between baseline, after the 6 weeks' program
|
Changes in Quality of life :
Time Frame: Comparison between baseline, after the 6 weeks' program
|
Health related quality of life will be measured with the EORTC Quality of Life Questionnaire QLQ-C30 which is a cancer specific questionnaire.
It consists in 30 items to measure 15 dimensions of quality of life.
It generates a score between 0 and 100.
A higher score means a higher quality of life level.
|
Comparison between baseline, after the 6 weeks' program
|
Changes in Fatigue :
Time Frame: Comparison between baseline, after the 6 weeks' program
|
Fatigue will be measured with the Quality of Life Questionnaire QLQ-FA12 which enables to assess cancer related fatigue.
It consists in 12 items to measure 5 dimension go health related fatigue.
It generates a score between 0 and 100.
A higher score means a higher fatigue level.
|
Comparison between baseline, after the 6 weeks' program
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-A02992-51
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Liver Cancer
-
University of HawaiiGlaxoSmithKlineRecruitingAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Liver CancerUnited States
-
University of CincinnatiActive, not recruitingLiver Metastases | Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | Stage A Adult Primary Liver Cancer (BCLC) | Stage B Adult Primary Liver Cancer (BCLC)United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Genoscience PharmaNot yet recruiting
-
Slawa CwajnaNova Scotia Health AuthorityWithdrawnPrimary Liver Cancer | Metastatic Liver CancerCanada
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | Stage I Adult Primary Liver Cancer | Stage II Adult Primary Liver Cancer | Stage IIIA Adult Primary Liver Cancer
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting
Clinical Trials on Standard Oncologic care
-
University GhentVrije Universiteit Brussel; Fund for Scientific Research, Flanders, BelgiumCompletedLife-limiting Cancer With Prognosis of Approximately 1 YearBelgium
-
European Organisation for Research and Treatment...Not yet recruiting
-
Rutgers, The State University of New JerseyRecruitingMetastatic Cancer | Radiation TherapyUnited States
-
National Cancer Center, KoreaCompletedDepression | Pancreatic Cancer | Biliary Tract Cancer | Cancer PainKorea, Republic of
-
St. James's Hospital, IrelandKarolinska Institutet; St Mary's Hospital, Paddington, LondonCompletedEsophageal Cancer | Chemoradiation | Chemotherapy | Surgery | Metastatic Cancer | Radiation | Recurrent Esophageal CancerSweden, Ireland, United Kingdom
-
Ankara City Hospital BilkentNot yet recruitingAcute Renal Injury | Geriatrics | Gynecologic SurgeryTurkey
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France